ERBB2 and breast carcinoma: In summary, the data presented here suggest that amplification of chromosomal regions 17q21.33-q25.1, 8p11.2 and 8q24.3 is strongly associated with early relapse in early stage ER+/HER2- breast cancers treated with hormonal therapy, and correlates with high Oncotype Dx recurrence scores.